Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 2
1995 2
1996 1
1997 3
2003 2
2005 2
2006 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative Group.
González Barón M, Feliu J, Espinosa E, García Girón C, Blanco E, Garrido P, Colmenarejo A, Ordóñez A, Moyano A, de la Gándara I, et al. González Barón M, et al. Among authors: colmenarejo a. Ann Oncol. 1994 Apr;5(4):323-7. doi: 10.1093/oxfordjournals.annonc.a058834. Ann Oncol. 1994. PMID: 8075028 Free article. Clinical Trial.
Treatment of advanced gastric cancer with the combination fluorouracil, leucovorin, etoposide, and cisplatin: a phase II study of the ONCOPAZ Cooperative Group.
González-Barón M, Feliu J, Espinosa E, García-Girón C, Chacón I, Garrido P, Colmenarejo A, Ordóñez A, Zamora P. González-Barón M, et al. Among authors: colmenarejo a. Cancer Chemother Pharmacol. 1995;36(3):255-8. doi: 10.1007/BF00685856. Cancer Chemother Pharmacol. 1995. PMID: 7781148 Clinical Trial.
Activity and safety of oxaliplatin with weekly 5-fluorouracil bolus and low-dose leucovorin as first-line treatment for advanced colorectal cancer.
Cassinello J, Escudero P, Salud A, Marcos F, Pujol E, Pérez-Carrión R, Colmenarejo A, González del Val R, Valero J, Oruezábal MJ, Guillem V, García I, Arcediano A, Marfà X. Cassinello J, et al. Among authors: colmenarejo a. Clin Colorectal Cancer. 2003 Aug;3(2):108-12. doi: 10.3816/CCC.2003.n.017. Clin Colorectal Cancer. 2003. PMID: 12952567 Clinical Trial.
Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer.
Cassinello J, Alvarez JV, López MJ, Pujol E, Colmenarejo A, Segovia F, Marcos F, Filipovich E, Arcediano A, Castro IG. Cassinello J, et al. Among authors: colmenarejo a. Clin Colorectal Cancer. 2006 Mar;5(6):429-35. doi: 10.3816/ccc.2006.n.014. Clin Colorectal Cancer. 2006. PMID: 16635282 Clinical Trial.
Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.
de Carpeño JC, Barón MG, Aguiar J, Chacón JI, Feliu J, García MJ, Madroñal C, Colmenarejo A, Sánchez JJ, Ordóñez A; Oncopaz Cooperative Group (Spain). de Carpeño JC, et al. Among authors: colmenarejo a. Cancer Chemother Pharmacol. 2006 Aug;58(2):266-71. doi: 10.1007/s00280-005-0143-z. Epub 2005 Nov 25. Cancer Chemother Pharmacol. 2006. PMID: 16308698
15 results